IL6 and metabolic dysfunction-associated steatotic liver disease: IL-6 is susceptible to production induced by TNF-α, which can worsen hepatic steatosis, insulin resistance, and inflammation in the pathogenesis of NAFLD, thereby facilitating the onset and progression of the disorder (Cengiz et al., 2014).